To whom should a patient with Hidradenitis Suppurativa (HS) be referred for management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Referral Pathways for Hidradenitis Suppurativa

For patients with Hurley Stage III (severe) disease, immediately refer to dermatology secondary care; for all patients with HS requiring surgical intervention, refer to a multidisciplinary team that includes dermatology and surgery. 1

Primary Referral Decision Based on Disease Severity

Immediate dermatology referral is indicated for:

  • Hurley Stage III disease (extensive disease with multiple interconnected sinus tracts, abscesses, and diffuse scarring across an anatomical region) 1
  • Patients unresponsive to first-line oral antibiotics (tetracyclines) after 12 weeks 1
  • Patients requiring biologic therapy (adalimumab, infliximab) for moderate-to-severe disease 1

Dermatology referral should be considered for:

  • Hurley Stage II disease with recurrent abscesses and limited sinus tracts that may benefit from specialist medical management 2, 3
  • Patients requiring second-line antibiotic therapy (clindamycin plus rifampicin combination) 1
  • Diagnostic uncertainty or atypical presentations 4, 5

Multidisciplinary Team Referral

All patients with HS should be managed via a multidisciplinary team approach, particularly when considering surgical interventions. 1 This team may include:

  • Dermatology (primary specialist for medical management and biologic therapy) 1
  • General surgery or plastic surgery (for surgical excision, deroofing procedures, and wound reconstruction) 1, 6
  • Pain management specialists (for patients with severe chronic pain) 1
  • Mental health services (for screening and treatment of depression and anxiety, which are common comorbidities) 1

The British Association of Dermatologists explicitly states that management strategies span multiple specialties including emergency medicine, internal medicine, dermatology, plastic surgery, urology, gynecology, and general surgery. 1

Ancillary Service Referrals

Mandatory referrals for risk factor modification:

  • Smoking cessation services for all patients who smoke (smoking has an odds ratio of 36 for HS) 1, 2
  • Weight management services for patients with elevated BMI (obesity has an odds ratio of 33 for HS) 1, 2

Comorbidity-specific referrals:

  • Gastroenterology if persistent gastrointestinal symptoms are present (to screen for inflammatory bowel disease) 1
  • Endocrinology for patients with diabetes, metabolic syndrome, or polycystic ovary syndrome 1, 2
  • Cardiology or primary care for cardiovascular risk factor management (hypertension, hyperlipidemia) 1

Timing of Surgical Referral

Surgical referral is appropriate for:

  • Hurley Stage III disease with extensive sinus tracts and scarring requiring radical excision 6, 2
  • Hurley Stage II disease with established sinus tracts that may benefit from deroofing or wide local excision 2, 3
  • Acute flares requiring incision and drainage (may be managed in emergency department or by surgery) 1, 4
  • Patients with long-standing disease at risk for cutaneous squamous cell carcinoma 1

Combining adalimumab with surgery results in greater clinical effectiveness than adalimumab monotherapy alone, so consider concurrent medical and surgical management for advanced disease. 2, 3

Critical Pitfalls to Avoid

  • Do not delay dermatology referral for Hurley Stage III disease while attempting multiple courses of antibiotics, as early specialist intervention improves outcomes 1
  • Do not refer to general surgery alone without dermatology involvement, as medical optimization with biologics may reduce surgical morbidity 1, 6
  • Do not overlook mental health referral, as HS significantly impairs quality of life to a greater degree than many other dermatologic conditions 1, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hidradenitis Suppurativa Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hidradenitis Suppurativa Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Extensive Perianal Hidradenitis Suppurativa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.